Pravastatin Sodium - Indication, Dosage, Precautions, Side Effects, and Pharmacological Aspects

What Is Pravastatin Sodium?

Pravastatin sodium is taken along with a nutritious diet to increase good cholesterol (HDL: high-density lipoproteins) and decrease bad cholesterol and fats (such as low-density lipoproteins and triglycerides) in the blood. It is a member of the class of medications known as statins. It functions by reducing the quantity of cholesterol the liver produces.

Along with adopting a healthy lifestyle (such as a low-cholesterol or low-fat diet), this medication may perform better if an individual exercises, loses weight (if overweight), and stops smoking.

Is Pravastatin Sodium Approved by the FDA?

In February 2000, the U.S. Food and Drug Administration (FDA) authorized the country's first sales of Pravastatin sodium.

Drug Group:

Statins are a group of lipid-lowering substances that lower cholesterol production, including Pravastatin sodium. The enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the initial rate-limiting step in cholesterol production (HMG-CoA to mevalonate), is competitively inhibited by these drugs.

Available Doses and Dosage Forms:

The drug is available in 10 mg (milligrams), 20 mg, 40 mg, and 80 mg. It is available as tablets for oral use.

How Does Pravastatin Sodium Work?

Pravastatin is a member of the class of drugs known as HMG-CoA reductase inhibitors, or statins.

Its mode of action is:

• To slow down the body's manufacture of cholesterol.

• This decrease in cholesterol synthesis reduces the risk of clogged blood flow to key organs, including the heart, brain, and other vital areas, by preventing cholesterol accumulation along arterial walls.

• The accumulation of cholesterol and fats along arterial walls, known as atherosclerosis, can lead to diminished blood circulation and reduced oxygen supply to essential organs.

• By effectively lowering cholesterol and lipid levels in the bloodstream, Pravastatin sodium has demonstrated its ability to serve as a preventive measure against conditions such as heart disease, angina (chest pain), strokes (hindered blood flow to brain cells), and heart attacks (collapsed cardiac blood flow).

What Are the Things to Inform the Doctor Before Taking the Drug?

Inform the doctor and chemist about any

• Vitamins, nutritional supplements, herbal items, and prescription and over-the-counter medicines that the patient intends to take.

• Tell the doctor if you take medicines like antacids, antifungal medicines, Cimetidine, Clarithromycin, Colchicine, Cyclosporine, Digoxin, Diltiazem, Erythromycin, cholesterol medicines like Gemfibrozil, Fenofibrate, and Niacin, Ritonavir or Darunavir, Spironolactone, Verapamil, and Warfarin. These medicines can mix badly with Pravastatin sodium. In such cases, the doctor may change the dose or watch the patient closely for side effects.

• If patients have allergies, especially to Pravastatin sodium, other drugs, or any ingredients in Pravastatin sodium pills, they should tell their doctor and pharmacist. To be sure they understand the medication's composition, they can also ask their chemist for a list of its constituents.

• If a patient has a history of liver illness, they should let their doctor know. Even if the patient does not suspect liver disease, the doctor will perform the necessary laboratory tests to evaluate liver function. The doctor would advise against taking Pravastatin sodium if the patient has liver disease or if the test findings show a chance of developing liver disease.

• If a person drinks more than two alcoholic beverages per day, is 65 years of age or older, has a history of liver illness, or has ever had seizures, low blood pressure, muscular pain, or weakness due to thyroid or renal disease, they should speak with their doctor. These particulars are necessary for the doctor to be thoroughly aware of the patient's medical history and present state of health.

• When using Pravastatin sodium, it is suggested not to get pregnant. It is advised to discuss appropriate birth control choices with the doctor while undergoing therapy. Pravastatin sodium must be stopped, and a doctor must be contacted immediately if pregnancy develops while taking the medication.

• It is not recommended to breastfeed while taking Pravastatin sodium. This safety measure is in place to protect the health of the person taking the medicine and the breastfeeding infant.

How Is Pravastatin Sodium Administered?

• Oral administration of Pravastatin sodium tablets is the recommended method.

• It can be taken with or without meals and is typically taken once a day. Sticking to a regular daily routine of taking

• Pravastatin sodium is the best action.

• It is crucial to follow the directions listed on the prescription label, and any questions should be answered by talking to a doctor or chemist.

• Take pravastatin sodium exactly as the doctor prescribed. Do not take more, less, or often.

• If the patient also takes cholesterol-lowering medicines like Colestipol or Cholestyramine, Pravastatin sodium should be taken 1 hour before or 4 hours after these medicines. Taking them together can prevent Pravastatin sodium from being properly absorbed.

• The doctor may start pravastatin sodium at a low dose, which may be gradually increased, with a frequency of no more than once every 4 weeks.

• Even if there is no discomfort, the person should continue to take Pravastatin sodium as prescribed.

• Pravastatin sodium discontinuation without a doctor's prescription is discouraged and should be avoided.

What Are the Side Effects of Pravastatin Sodium?

If the individual experiences any side effects from Pravastatin sodium, they should promptly inform their doctor if these symptoms persist, are bothersome, or worsen in severity.

• Loss of memory.

• Heartburn.

• Confusion.

• Headache.

The doctors should be contacted immediately for any of the severe side effects mentioned below:

• Yellowing of the eyes and skin.

• Dark-colored urine.

• Nausea.

• Tiredness.

• Weakness of the muscles.

• Pain and tenderness in the muscles.

• Rashes and itching.

• Hoarseness of the voice.

• Appetite loss.

• Symptoms similar to those of the flu.

• Difficulty swallowing and eating.

• Pain in the stomach (right side).

Dietary Considerations:

The person has to maintain a low-fat, low-cholesterol diet. It is essential to carefully follow any nutritional and exercise recommendations from your doctor or dietitian. This proactive approach will support the efficacy of their treatment plan and their wellness objectives.

Missed Dose:

If a dosage is forgotten, the person should take it as soon as they remember. It is advised to skip the missed dose and resume the regular dosing schedule if the next dose is almost due. To make up for a missed dose, it is not recommended to double the dose; therefore, refrain from doubling the dose. The success and safety of the medicine depend on consistent adherence to the recommended dose schedule.

Overdose:

In the event of overdosing, the nearest healthcare center’s doctor in charge should be consulted immediately.

Storage:

The drug should be kept in its original container, well closed, and out of the reach of children. It should not be kept in the bathroom; instead, it should be maintained at room temperature. Following these storage recommendations ensures that the drug is stable and safe.

For Doctors:

Indication: Utilization of lipid-altering medicines should be just one component of a larger approach involving several risk factor therapies for those with hypercholesterolemia and a markedly elevated risk for atherosclerotic vascular disease. Drug therapy becomes a vital supplementary strategy when dietary changes, such as limiting saturated fat and cholesterol, and other nonpharmacologic treatments, have failed to provide the desired results.

1. Cardiovascular Disease Prevention

Pravastatin Sodium is advised for use in hypercholesterolemia individuals without clinically noticeable coronary heart disease (CHD) to:

• To lower the chance of myocardial infarction (MI).

• To lessen the danger of myocardial revascularization treatments.

• To decrease the likelihood of cardiovascular death while maintaining the same rate of non-cardiovascular death.

2. Pravastatin Sodium Is Advised for People With Clinically Indicated CHD To:

• Decrease the risk of coronary death to lower the overall mortality risk.

• Decrease the chance of myocardial infarction (MI).

• Reduce the risk of myocardial revascularization procedures.

• This lessens the chance of having a stroke or a TIA (transient ischemic attack).

• Slows the development of coronary atherosclerosis.

3. Hyperlipidemia:

• Pravastatin sodium is used in patients with primary hypercholesterolemia and mixed dyslipidemia as an adjunct to diet to lower elevated total cholesterol (Total-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (ApoB), and triglyceride (TG) levels and to increase high-density lipoprotein cholesterol (HDL-C).

• It supplements the diet for treating individuals with high blood TG levels.

• It is used to treat individuals with primary dysbetalipoproteinemia (Fredrickson Type III) who do not improve with diet.

Dose: Available as 10 mg, 20 mg, 40 mg, and 80 mg tablets for oral consumption (taken orally).

Dosing Considerations: It is advised that the patient be put on a typical cholesterol-lowering diet before starting Pravastatin sodium therapy. This diet plan should be followed continuously throughout the duration of Pravastatin sodium medication.

1. For Adults:

• The recommended initial dosage is 40 milligrams (mg) once daily.

• If the required cholesterol levels are not reached with the recommended first dosage of 40 mg once a day, an increase to 80 mg once a day is indicated.

• A starting dosage of 10 mg per day is suggested for people with significant renal impairment.

• Pravastatin sodium is administered orally and may be taken once daily, regardless of food intake.

2. For Pediatric Population:

• Age Ranging From 8 to 13 Years - For youngsters aged 8 to 13, a dosage of 20 mg once daily is advised. No research has been done on doses higher than 20 mg in this patient population.

• Age Ranging From 14 to 18 Years - For teenagers aged 14 to 18, a starting dose of 40 mg once daily is advised. This patient population has not been investigated at doses higher than 40 mg.

3. For Patients on Cyclosporine Therapy:

Pravastatin sodium treatment should start with a dose of 10 mg once a day at bedtime in patients who are also on immunosuppressive medications like Cyclosporine, and titration to higher dosages should be done carefully. The average Pravastatin sodium dosage in this combination is 20 mg daily.

What Are the Pharmacological Aspects of Pravastatin Sodium?

1. Physical Properties of the Drug:

• Drug Group - Statins.

• Appearance - White to off-white, odorless, fine, or crystalline powder.

• Chemical Name - 1-Naphthalene-heptanoic acid, 1,2,6,7,8,8ahexahydro-β,δ,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S­[1α(βS*,δS*),2α,6α,8β(R*),8aα]].

• Empirical Formula - C23H35NaO7.

• Molecular Weight - 446.52.

• Solubility - Soluble in methanol and water. Almost insoluble in acetone, acetonitrile, chloroform, and ether, and just slightly soluble in isopropanol.

• Components of the Drug - Microcrystalline cellulose, lactose, magnesium stearate, magnesium oxide, and croscarmellose sodium.

2. Mechanism of Action:

• Pravastatin sodium lowers LDL by interacting via two distinct mechanisms.

• It works by inhibiting HMG-CoA reductase in the main route. Pravastatin sodium interferes with the HMG-CoA reductase enzyme's ability to perform its function by acting as a reversible competitive inhibitor. The conversion of HMG-CoA to mevalonate, a critical step in cholesterol production, is controlled by this enzymatic activity, which predominantly occurs in the liver.

• Pravastatin sodium simultaneously prevents the production of very low-density lipoproteins (VLDL), which are the building blocks of low-density lipoproteins (LDL).

• These activities increase the number of cellular LDL receptors. As a result, this enhancement improves the absorption of LDL from the circulation, simplifying its elimination.

• A decrease in LDL and circulating cholesterol levels follows from these individual effects.

• Other typical results include a small decrease in triglycerides and a simultaneous increase in high-density lipoproteins (HDL).

3. Pharmacokinetics:

Absorption:

• Pravastatin sodium is taken orally to deliver the active form.

• According to clinical investigations in humans, pravastatin sodium generally reaches its peak plasma concentrations one to two hours after oral administration.

• Based on urine recovery of the entire radiolabeled dose, Pravastatin sodium has an average oral absorption rate of about 34 percent, yielding an absolute bioavailability of about 17 percent.

• The presence of food in the digestive tract may reduce systemic bioavailability.

• However, the medication's lipid-lowering effects are the same whether taken together with or eaten an hour before meals.

Distribution: About 50% of the medication in circulation is bound to plasma proteins.

Metabolism: 3 alpha-hydroxy Pravastatin sodium is the primary active metabolite of Pravastatin sodium. The parent drug's cholesterol-lowering properties are carried over into this metabolite. In the liver, Pravastatin sodium undergoes extensive first-pass metabolism before being partially converted to its active form.

Excretion: About 20 percent of an oral radiolabeled dosage is delivered and excreted through the urinary system, and roughly 70 percent is removed through the feces. In healthy individuals, renal excretion accounts for about 47 percent of the total body clearance of radiolabeled Pravastatin sodium; non-renal routes, such as biliary excretion and biotransformation, clear the other 53%.

Clinical Studies:

Individuals with familial and nonfamilial polygenic hypercholesterolemia, as well as those with diabetes mellitus, have shown that Pravastatin sodium is beneficial in decreasing cholesterol levels. Pravastatin sodium can lower LDL cholesterol by 15 to 40 percent and total cholesterol by 15 to 30 percent when taken daily at doses of 10 to 40 mg.

Additionally, it causes a 2-20% increase in high-density lipoprotein cholesterol and simultaneously lowers triglyceride levels. Pravastatin sodium is typically well tolerated, with few adverse effects reported in clinical trials. Pravastatin sodium yields reductions in LDL cholesterol and increases in HDL cholesterol comparable to those of Lovastatin, possibly with a reduced incidence of side effects.

What Are the Contraindications of Pravastatin Sodium?

• Hypersensitivity.

• Pregnancy.

• Lactation.

• Liver disease.

• Disorders of the skeletal muscles.

Warnings and Precautions:

1. Skeletal Muscles:

• Pravastatin sodium may cause myalgia, rhabdomyolysis, myopathy, and increased creatine phosphokinase levels (CPK). If there is a considerable increase in CPK levels or the patient has myopathy confirmed or suspected, Pravastatin sodium medication must be stopped immediately.

• Pravastatin sodium usage should also be temporarily stopped for individuals suffering from rhabdomyolysis or who are dealing with an acute or serious medical condition that raises the risk of renal failure brought on by rhabdomyolysis. Serious metabolic or endocrine problems, trauma, sepsis, hypotension, severe surgery, electrolyte imbalances, or uncontrolled epilepsy are a few examples of such circumstances.

• When statins are used with drugs like Erythromycin, Cyclosporine, Niacin, or fibrates, the risk of myopathy increases, although the danger of myopathy is occasionally associated with using Fibrates alone. Using them in combination with Pravastatin sodium demands careful consideration.

• Given the potential hazards associated with this combination, it is wise to weigh the potential benefits of further lipid-lowering modifications against the combined use of Pravastatin sodium and Fibrates.

2. Liver:

Anomalies in liver function have been connected to statin use. Liver function tests are advised before starting treatment and whenever necessary. Medication should be stopped immediately for serious liver damage, high bilirubin levels, or jaundice. Resuming Pravastatin sodium is not advised if no other cause has been found.

3. Endocrine Functions:

• Statins prevent the synthesis of new cholesterol, thereby reducing blood cholesterol levels. This method could affect steroid hormones in the gonads or adrenal glands. However, the results of clinical trials conducted for Pravastatin sodium in post-menopausal women and men yielded conflicting results regarding the drug's possible impact on steroid hormone levels at rest.

• More patient research is needed to determine how statins affect spermatogenesis and fertility.

• Pravastatin sodium-treated patients with clinical signs of endocrine disruption must undergo the proper testing.

• Additionally, care should be taken when administering a statin or other cholesterol-lowering medication to patients who are also taking medications (such as Cimetidine, Ketoconazole, or Spironolactone) that may reduce the production or action of steroid hormones.

What Are the Drug Interactions of Pravastatin Sodium?

1. Cyclosporine - When Cyclosporine is administered concurrently, the risk of myopathy and rhabdomyolysis increases. Pravastatin sodium dosage for concurrent Cyclosporine usage should be limited to 20 mg once daily.

2. Clarithromycin - When Clarithromycin is administered concurrently, the risk of myopathy and rhabdomyolysis increases. Pravastatin sodium should not be used with Clarithromycin at doses greater than 40 mg once daily.

3. Gemfibrozil - Concomitant administration of Pravastatin sodium with Gemfibrozil should be avoided due to an increased risk of myopathy or rhabdomyolysis when HMG-CoA reductase inhibitors are used.

4. Niacin - When Pravastatin sodium is used with Niacin, the risk of adverse effects on the skeletal muscle may be increased. In this situation, a reduction in Pravastatin sodium dose should be considered.

5. Colchicine - When Colchicine is administered concurrently with Pravastatin sodium, the risk of myopathy and rhabdomyolysis increases.

6. Other Fibrates - As concurrent use of other fibrates is known to enhance the risk of myopathy during therapy with HMG-CoA reductase inhibitors, Pravastatin sodium should be taken cautiously.

Specific Considerations:

• Pregnancy - It is unknown whether taking Pravastatin sodium while pregnant is safe. There are no comprehensive and controlled studies that include pregnant women, even though there are examples of unintended Pravastatin sodium exposure during pregnancy that do not show any adverse clinical effects. As a result, it is unclear how Pravastatin sodium may affect fetal health or a woman's capacity to become pregnant. When the benefits surpass any possible dangers to the fetus, Pravastatin sodium use during pregnancy should be considered. Patients in these situations must be fully educated about the risks before making a choice.

• Lactation - Care should be taken since Pravastatin sodium is excreted in small amounts in human breast milk. Breastfeeding is not advised for mothers who are taking Pravastatin sodium due to the possibility of serious adverse effects on nursing babies.

• Pediatric Population - The pediatric population has not been studied for doses of 40 mg or higher. It is advised that pregnant women and young women on Pravastatin sodium get in-depth counseling on the best methods of contraception. No studies have been done on double-blind, placebo-controlled Pravastatin sodium trials with kids under the age of eight. According to research on children aged 8 to 18, the most common adverse effects reported were headaches and influenza.

• Geriatric Population - Pravastatin sodium has a similar beneficial effect on older people as it does on younger people. This includes reductions in cardiovascular events and changes in lipid profiles. Adverse events occurring in the elderly were similar to those seen in the general population. Pravastatin sodium should be given to seniors with caution and moderation since advanced age (65 years or more) is a known risk factor for myopathy.

• Homozygous Familial Hypercholesterolemia - In individuals with rare homozygous familial hypercholesterolemia, Pravastatin sodium has not been studied. Statins are less effective in this patient population because they lack functional LDL receptors.